frenzied flea
"Noel D. Herring" <[email protected]> Mon, 1 Jan 2007 15:40:51 +0900
| Newsgroups | gmane.comp.video.info-performer.cvs,gmane.spam.detected |
|---|---|
| Message-ID | <000901c72d70$2bc0c830$894d1b3d@ctp> |
No part of this document may be reproduced in any manner without written permission of AlphaProfit Investments, LLC. Distribution problems, which are likely going to be short-lived, have forced a discount on Wild Oats shares. Alternatively, an investor can take a proactive approach to maximize the potential of sector funds by periodically switching assets into sectors with higher expected returns. Approval times for new drugs have been significantly reduced. Competition in this industry is brutal and supermarket shares have been far from safe. A combination of declining domestic oil production and increasing oil consumption has left the U. "We opened the coffin of Saddam. " The Wal-Mart juggernaut and stiff competition will always be a threat, so keep your eyes wide open. If the company can continue to acquire and successfully integrate publicly and privately held regional chains, this David perhaps can take on the Wal-Mart Goliath. About AlphaProfitAlphaProfit Investments, LLC, is a Houston, TX based investment research firm that publishes the AlphaProfit Sector Investors' Newsletter. What Subscribers SayThe industry has been getting its act together on the pricing front for some time. Opinions expressed herein reflect the opinion of AlphaProfit Investments, LLC and are subject to change without notice. With the growth and excitement of new products and applications, the biotechnology industry group has seldom been fertile ground for the traditional value investor. The Motley Fool is Fools writing for Fools. Analysts weigh in on how Saddam Hussein's death will impact Iraqi tensions. While biotechnology firms seek to merge among themselves, pharmaceutical companies are also targeting biotechnology companies.
good-natured.gif
(image/gif, 9 KB) - not displayed